{{Rsnum
|rsid=4713518
|Chromosome=6
|position=32289560
|Orientation=plus
|GMAF=0.3375
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 36.3 | 48.7 | 15.0
| HCB | 30.7 | 56.9 | 12.4
| JPT | 37.2 | 54.9 | 8.0
| YRI | 84.4 | 14.3 | 1.4
| ASW | 73.7 | 22.8 | 3.5
| CHB | 30.7 | 56.9 | 12.4
| CHD | 36.4 | 48.6 | 15.0
| GIH | 32.7 | 50.5 | 16.8
| LWK | 80.0 | 20.0 | 0.0
| MEX | 15.5 | 58.6 | 25.9
| MKK | 60.6 | 35.5 | 3.9
| TSI | 26.7 | 58.4 | 14.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs4713518
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:16998491
|Annotation=Risk or phenotype-associated allele: allele 1. Phenotype: Combined alleles of rs3134792 (3) and rs4713518 (1) are tagging SNPs for HLA-B*5801. Study size: 45. Study population/ethnicity: Unrelated Han Chinese from Beijing, China. Significance metric(s): Type of association: GN
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291980
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4713518
|overall_frequency_n=41
|overall_frequency_d=128
|overall_frequency=0.320312
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}